Report: Tracking system needed to fight fake drugs

February 13, 2013 by Lauran Neergaard

(AP)—A new report calls for a national drug tracking system to fight the growing problem of fake drugs.

The Institute of Medicine says phony or substandard drugs are an increasing international threat, and one that is affecting the U.S. as well.

Just last week, the warned doctors—for the third time in about a year—that it discovered a counterfeit batch of the cancer drug Avastin, one that lacks the real tumor-killing ingredient.

Wednesday's report says mandatory drug tracking would offer the same kind of reliability for medications that the U.S. court system's chain-of-custody requirements do for evidence used in trials. It would allow verification that a drug and the ingredients used to make it are authentic at every step.

Explore further: Roche warns of counterfeit cancer drug in US

shares

Related Stories

Roche warns of counterfeit cancer drug in US

February 14, 2012
(AP) -- The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S.

US warns of new fake batch of cancer drug Avastin

February 6, 2013
The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.

Fake Avastin contained several chemicals, no drug

February 28, 2012
(AP) -- Counterfeit versions of the popular cancer drug Avastin obtained by European regulators contain a variety of chemicals, but not the active ingredient found in the genuine drug, according to drugmaker Roche.

FDA finds more vials of fake cancer drug

April 4, 2012
(AP) -- The Food and Drug Administration is warning doctors that a second counterfeit version of the best-selling cancer drug Avastin has been found in the U.S., packaged as the Turkish brand of the medication.

China arrests nearly 2,000 in fake drug crackdown

August 6, 2012
(AP) — China's Ministry of Public Security says it has detained nearly 2,000 people in a nationwide crackdown on counterfeit drugs, including some to treat cancer.

FDA warns of fake version of ADHD drug Adderall

May 30, 2012
(HealthDay) -- A counterfeit version of the attention-deficit/hyperactivity disorder drug Adderall, sold online, contains the wrong active ingredients, according to the U.S. Food and Drug Administration.

Recommended for you

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.